Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
Open accessThe DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Abstract
The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26 million people suffering from CKD in the United States alone. More patients with CKD die of cardiovascular complications than progress to dialysis. Over 80% of CKD patients have hypertension, which is associated with increased risk of cardiovascular morbidity and mortality. Another common, perhaps underappreciated, feature of CKD is an overactive sympathetic nervous system. This elevation in sympathetic nerve activity (SNA) not only contributes to hypertension but also plays a detrimental role in the progression of CKD independent of any increase in blood pressure. Indeed, high SNA is associated with poor prognosis and increased cardiovascular morbidity and mortality independent of its effect on blood pressure. This brief review will discuss some of the consequences of sympathetic overactivity and highlight some of the potential pathways contributing to chronically elevated SNA in CKD. Mechanisms leading to chronic sympathoexcitation in CKD are complex, multifactorial and to date, not completely understood. Identification of the mechanisms and/or signals leading to sympathetic overactivity in CKD are crucial for development of effective therapeutic targets to reduce the increased cardiovascular risk in this patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Original record of muscle sympathetic nerve activity (MSNA) in a normal subject and a renal failure patient on hemodialysis, demonstrating significantly greater resting MSNA in the dialysis patient. The bottom two panels display a portion of the neurogram and simultaneous electrocardiogram from the patient on hemodialysis showing that the renal failure patient has a burst of MSNA with every cardiac cycle. (Modified from Converse et al. [11] with permission).](https://figures.cochat.ai/paper-figures/c29f315edad14e6d80676416128a09dc/sympathetic-overactivity-in-chronic-kidney-disease-consequences-and-mechanisms-figure-1.jpg)
![Figure 2 Muscle sympathetic nerve activity (MSNA) expressed as burst frequency (bursts (bs)/min, A) and burst incidence (bs/100 heartbeats (hb), B) in subjects grouped according to their estimated glomerular filtration rate (eGFR), with the highest quartile of eGFR in group I and lowest quartile of eGFR in group IV. With decreasing eGFR, there is a significant and progressive increase in resting MSNA in chronic kidney disease (CKD) patients. * p < 0.05 significant difference between quartiles. (From Grassi et al. [13] with permission).](https://figures.cochat.ai/paper-figures/b4ac89c6b0474f7ca430dc2de3b4c6dc/sympathetic-overactivity-in-chronic-kidney-disease-consequences-and-mechanisms-figure-2.jpg)
![Figure 3 Mean arterial pressure (MAP) responses during 8-h continuous systemic infusion of the nitric oxide synthase (NOS) inhibitor l-nitroarginine methyl ester (l-NAME) in rats with sympathectomy (open circles) and without sympathectomy (closed circles). Although no difference was observed in the initial increase in MAP (removal of endothelium-mediated dilation), sympathectomy attenuated the sustained hypertensive response to l-NAME, demonstrating a sympathetic contribution to the blood pressure raising effects of systemic NOS inhibition. * p < 0.05 vs. control. (From Sander et al. [75] with permission).](https://figures.cochat.ai/paper-figures/c4fa82d6798d4656876e51594ce8db56/sympathetic-overactivity-in-chronic-kidney-disease-consequences-and-mechanisms-figure-3.jpg)
![Figure 4 Average mean arterial pressure, heart rate, and renal sympathetic nerve activity during continuous systemic infusion of asymmetric dimethylarginine (ADMA; an endogenous NOS inhibitor) in baroreceptor-intact (A) and baroreceptor-denervated animals (B). In comparison with barointact animals, barodenervated animals show a significant increase in renal SNA indicating frank sympathoexcitation in response to systemic ADMA infusion. * p < 0.05 vs. baseline; † p < 0.05 vs. baroreceptor intact. (From Augutyniak et al. [87] with permission.)](https://figures.cochat.ai/paper-figures/c6752938f9484a64b8856be4cf6b53c4/sympathetic-overactivity-in-chronic-kidney-disease-consequences-and-mechanisms-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Elevated sympathetic nerve activity is a hallmark of CKD104 that is evident even in the early stages of the disease and correlates inversely with estimated glomerular filtration rate (eGFR) and disease progression105.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [104]
In the citing paper
“The occur-rence of increased SNS activity in hypertension and CKD is well established83,162.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [162]
In the citing paper
“Modulation of the gut microbiota reduces systemic inflammation and SNS activity, both of which contribute to hypertension and CKD80,162,208.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · cited 1×
“More than 26 million people in the United States suffer from chronic kidney disease (CKD) with thousands of new cases diagnosed each year [1].”
Background(2010) · The Lancet · doi:10.1016/s0140-6736(10)60674-5 · Cited by 4,200 · cited 1×
“Moderate to severe CKD (stage 3–5) is associated with a significantly higher risk of cardiovascular (CV) morbidity and mortality [4,5].”
BackgroundAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Li, Y., Robinson, B., Abbott, K. C., Agodoa, L. Y. C., Ayanian, J., Bragg-Gresham, J., Balkrishnan, R., Chen, J. L. T., Cope, E., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.014 · Cited by 1,155
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132 · cited 2×
“[11] was the first to report elevated resting MSNA in renal failure patients on hemodialysis (Figure 1).”
BackgroundZoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Boaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Knecht, A., Weissgarten, Y., Brunner, D., Fainaru, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02783-5 · Cited by 1,025
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Oberg, B. P., McMenamin, E., Lucas, F. L., McMonagle, E., Morrow, J., Ikizler, T. A. L. P., & Himmelfarb, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00465.x · Cited by 781
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, M., & Dzau, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Li, Y., Robinson, B., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Chen, J. T. L., Cope, E., Gipson, D., He, K., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.001 · Cited by 656
Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 631
Simpson, P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111023 · Cited by 618
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension
Bisognano, J. D., Bakris, G., Nadim, M. K., Sanchez, L., Kroon, A. A., Schafer, J., de Leeuw, P. W., & Sica, D. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.008 · Cited by 600
Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Coresh, J., Wei, G. L., McQuillan, G., Brancati, F. L., Levey, A. S., Jones, C., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 587
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553 · cited 2×
“It is produced by post-translational methylation of proteins via the enzyme arginine methyltransferase type I [95,99] and it is either metabolized by the dimethylarginine dimethylaminohydrolase (DDAH) enzyme or excreted by the kidneys [99,100].”
BackgroundReid, I. A. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.6.e763 · Cited by 552
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526
Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519 · cited 1×
“There is growing evidence that sympathetic overactivity, a characteristic feature of CKD, is one of the major mechanisms leading to higher CV risk in this patient population [9,10].”
BackgroundSympathetic Nerve Activity in End-Stage Renal Disease
Hausberg, M., Kosch, M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., & Rahn, K. H. (2002) · Circulation · doi:10.1161/01.cir.0000034043.16664.96 · Cited by 493
Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure
Xu, J., Li, G., Wang, P., Velazquez, H., Yao, X., Li, Y., Wu, Y., Peixoto, A., Crowley, S., & Desir, G. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524066 · Cited by 466
Collins, A. J., Foley, R. N., Gilbertson, D. T., & Chen, S.-C. (2015) · Kidney International Supplements · doi:10.1038/kisup.2015.2 · Cited by 452
Vallon, V., Mühlbauer, B., & Osswald, H. (2006) · Physiological Reviews · doi:10.1152/physrev.00031.2005 · Cited by 448
Heusser, K., Tank, J., Engeli, S., Diedrich, A., Menne, J., Eckert, S., Peters, T., Sweep, F. C. G. J., Haller, H., Pichlmaier, A. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140665 · Cited by 433
Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD
Dounousi, E., Papavasiliou, E., Makedou, A., Ioannou, K., Katopodis, K. P., Tselepis, A., Siamopoulos, K. C., & Tsakiris, D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.015 · Cited by 410
Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure
Ligtenberg, G., Blankestijn, P. J., Oey, P. L., Klein, I. H. H., Dijkhorst-Oei, L.-T., Boomsma, F., Wieneke, G. H., van Huffelen, A. C., & Koomans, H. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401704 · Cited by 409
Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System
Zimmerman, M. C., Lazartigues, E., Lang, J. A., Sinnayah, P., Ahmad, I. M., Spitz, D. R., & Davisson, R. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043501.47934.fa · Cited by 394
Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 384
Sakuma, I., Togashi, H., Yoshioka, M., Saito, H., Yanagida, M., Tamura, M., Kobayashi, T., Yasuda, H., Gross, S. S., & Levi, R. (1992) · Circulation Research · doi:10.1161/01.res.70.3.607 · Cited by 384 · cited 2×
“To eliminate the influence of the arterial baroreflex, the effect of systemic NOS inhibition was compared between barointact and barodenervated animals [74,87].”
BackgroundRavani, P., Tripepi, G., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 381
Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation
Hijmering, M. L., Stroes, E. S. G., Olijhoek, J., Hutten, B. A., Blankestijn, P. J., & Rabelink, T. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01786-7 · Cited by 362
Renal Denervation in Moderate to Severe CKD
Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Böhm, M., Cremers, B., Esler, M. D., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111062 · Cited by 361
Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure
Campese, V. M., & Kogosov, E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.878 · Cited by 356 · cited 2×
“Selective removal of afferent nerves (dorsal rhizotomy) in these animals prevents both the development of hypertension and increase in norepinephrine turnover in hypothalamic nuclei in the brain [61].”
BackgroundRole of nitric oxide in cardiovascular disease: focus on the endothelium
Cannon, R. O. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1809 · Cited by 349
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C., Bode-Bo[Combining Diaeresis]ger, S. M., Haller, H., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020179 · Cited by 312
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure
Grassi, G., Quarti-Trevano, F., Seravalle, G., Arenare, F., Volpe, M., Furiani, S., Dell'Oro, R., & Mancia, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164780 · Cited by 311
Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000128695.49900.12 · Cited by 306
Harada, S., Tokunaga, S., Momohara, M., Masaki, H., Tagawa, T., Imaizumi, T., & Takeshita, A. (1993) · Circulation Research · doi:10.1161/01.res.72.3.511 · Cited by 275
A central nervous system action of nitric oxide in blood pressure regulation
Togashi, H., Sakuma, I., Yoshioka, M., Kobayashi, T., Yasuda, H., Kitabatake, A., Saito, H., Gross, S. S., & Levi, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10757-x · Cited by 270 · cited 1×
“Other animal studies involved intravenous infusion, interacisternal injection or microinjection of NOS inhibitors into the paraventricular nucleus (PVN) and the NTS, demonstrating acute increases in renal SNA and blood pressure [74,80,82].”
BackgroundMedical Costs of CKD in the Medicare Population
Honeycutt, A. A., Segel, J. E., Zhuo, X., Hoerger, T. J., Imai, K., & Williams, D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040392 · Cited by 261
Laks, M. M., Morady, F., & Swan, H. J. C. (1973) · Chest · doi:10.1378/chest.64.1.75 · Cited by 260
Sympathetic nervous system and the kidney in hypertension
DiBona, G. F. (2002) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200203000-00011 · Cited by 252
Sympathetic Activity Is Increased in Polycystic Kidney Disease and Is Associated with Hypertension
KLEIN, I. H. H. T., LIGTENBERG, G., OEY, P. L., KOOMANS, H. A., & BLANKESTIJN, P. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112427 · Cited by 248
Social Stress and Atherosclerosis in Normocholesterolemic Monkeys
Kaplan, J. R., Manuck, S. B., Clarkson, T. B., Lusso, F. M., Taub, D. M., & Miller, E. W. (1983) · Science · doi:10.1126/science.6836311 · Cited by 247
Sympathetic activation decreases medium-sized arterial compliance in humans
Boutouyrie, P., Lacolley, P., Girerd, X., Beck, L., Safar, M., & Laurent, S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.4.h1368 · Cited by 240
Angiotensin receptors in the nervous system
Allen, A. M., Moeller, I., Jenkins, T. A., Zhuo, J., Aldred, G. P., Chai, S. Y., & Mendelsohn, F. A. O. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00039-2 · Cited by 226
Katholi, R. E., & Couri, D. M. (2011) · International Journal of Hypertension · doi:10.4061/2011/495349 · Cited by 219
Relationship between central sympathetic activity and stages of human hypertension
Smith, P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.10.010 · Cited by 215
Chan, S. H. H., Hsu, K.-S., Huang, C.-C., Wang, L.-L., Ou, C.-C., & Chan, J. Y. H. (2005) · Circulation Research · doi:10.1161/01.res.0000185804.79157.c0 · Cited by 205
Central sympathetic overactivity: Maladies and mechanisms
Fisher, J. P., Young, C. N., & Fadel, P. J. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.02.003 · Cited by 204
Self-citationCatecholamines Regulate the Activity, Secretion, and Synthesis of Renalase
Li, G., Xu, J., Wang, P., Velazquez, H., Li, Y., Wu, Y., & Desir, G. V. (2008) · Circulation · doi:10.1161/circulationaha.107.732032 · Cited by 194
AMANN, K., RUMP, L. C., SIMONAVICIENE, A., OBERHAUSER, V., WESSELS, S., ORTH, S. R., GROSS, M.-L., KOCH, A., BIELENBERG, G. W., VAN KATS, J. P., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181469 · Cited by 192
Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity
Campese, V. M., Ye, S., Zhong, H., Yanamadala, V., Ye, Z., & Chiu, J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00619.2003 · Cited by 191
Hypertension and microvascular remodelling
Feihl, F., Liaudet, L., Levy, B. I., & Waeber, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn022 · Cited by 190
A Large Blood Pressure–Raising Effect of Nitric Oxide Synthase Inhibition in Humans
Sander, M., Chavoshan, B., & Victor, R. G. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.937 · Cited by 176
Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
Levey, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820463 · Cited by 171
Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat
Shapoval, L. N., Sagach, V. F., & Pobegailo, L. S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90430-2 · Cited by 171
Ye, S., Ozgur, B., & Campese, V. M. (1997) · Kidney International · doi:10.1038/ki.1997.103 · Cited by 167
Sympathetic Nerve Activity Is Inappropriately Increased in Chronic Renal Disease
Klein, I. H. H. T., Ligtenberg, G., Neumann, J., Oey, P. L., Koomans, H. A., & Blankestijn, P. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000098687.01005.a5 · Cited by 167
Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review
Green, D., Roberts, P. R., New, D. I., & Kalra, P. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.02.376 · Cited by 166
Overexpression of eNOS in the RVLM Causes Hypotension and Bradycardia Via GABA Release
Kishi, T., Hirooka, Y., Sakai, K., Shigematsu, H., Shimokawa, H., & Takeshita, A. (2001) · Hypertension · doi:10.1161/hyp.38.4.896 · Cited by 166
Trophic effects of peripheral adrenergic nerves on vascular structure.
Bevan, R. D. (1984) · Hypertension · doi:10.1161/01.hyp.6.6_pt_2.iii19 · Cited by 161
From molecules to mammals: what's NOS got to do with it?
Mungrue, I. N., Bredt, D. S., Stewart, D. J., & Husain, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01182.x · Cited by 160
Schlaich, M. P., Bart, B., Hering, D., Walton, A., Marusic, P., Mahfoud, F., Böhm, M., Lambert, E. A., Krum, H., Sobotka, P. A., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.218 · Cited by 155
Enalapril and Losartan Reduce Sympathetic Hyperactivity in Patients with Chronic Renal Failure
Klein, I. H. H. T., Ligtenberg, G., Oey, P. L., Koomans, H. A., & Blankestijn, P. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045049.72965.b7 · Cited by 151
Oliveira-Sales, E. B., Nishi, E. E., Carillo, B. A., Boim, M. A., Dolnikoff, M. S., Bergamaschi, C. T., & Campos, R. R. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.17 · Cited by 146
Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects
Failla, M., Grappiolo, A., Emanuelli, G., Vitale, G., Fraschini, N., Bigoni, M., Grieco, N., Denti, M., Giannattasio, C., & Mancia, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00011 · Cited by 136
Katholi, R. E., Whitlow, P. L., Hageman, G. R., & Woods, W. T. (1984) · PubMed · Cited by 136
Ye, S., Zhong, H., Yanamadala, V., & Campese, V. M. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02959-x · Cited by 135
Bevan, R. D. (1975) · Circulation Research · doi:10.1161/01.res.37.1.14 · Cited by 135
Oxidative Stress Mediates Angiotensin II–Dependent Stimulation of Sympathetic Nerve Activity
Campese, V. M., Shaohua, Y., & Huiquin, Z. (2005) · Hypertension · doi:10.1161/01.hyp.0000179088.57586.26 · Cited by 133
The sympathetic system in hypertension. State-of-the-art review
Abboud, F. M. (1982) · Hypertension · doi:10.1161/01.hyp.4.3.208 · Cited by 130
Gao, L., Wang, W., Li, Y.-L., Schultz, H. D., Liu, D., Cornish, K. G., & Zucker, I. H. (2005) · Circulation · doi:10.1161/circulationaha.105.552174 · Cited by 130
Katholi, R. E., Whitlow, P. L., Hageman, G. R., & Woods, T. W. (1984) · Journal of Hypertension · doi:10.1097/00004872-198402040-00005 · Cited by 129
Rafiq, K., Noma, T., Fujisawa, Y., Ishihara, Y., Arai, Y., Nabi, A. H. M. N., Suzuki, F., Nagai, Y., Nakano, D., Hitomi, H., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.064097 · Cited by 125
Hirooka, Y., Kishi, T., Sakai, K., Takeshita, A., & Sunagawa, K. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00426.2010 · Cited by 124
Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices.
Tagawa, T., Imaizumi, T., Harada, S., Endo, T., Shiramoto, M., Hirooka, Y., & Takeshita, A. (1994) · Circulation Research · doi:10.1161/01.res.75.1.70 · Cited by 123
STROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., & RITZ, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123602 · Cited by 112
Renalase in hypertension and kidney disease
Désir, G. V., & Peixoto, A. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft083 · Cited by 108
Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?
Hansen, J., Jacobsen, T. N., & Victor, R. G. (1994) · Hypertension · doi:10.1161/01.hyp.24.4.439 · Cited by 108
Wakino, S., Hayashi, K., Tatematsu, S., Hasegawa, K., Takamatsu, I., Kanda, T., Homma, K., Yoshioka, K., Sugano, N., & Saruta, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.255 · Cited by 108
Renal Denervation Does Not Abolish Sustained Baroreflex-Mediated Reductions in Arterial Pressure
Lohmeier, T. E., Hildebrandt, D. A., Dwyer, T. M., Barrett, A. M., Irwin, E. D., Rossing, M. A., & Kieval, R. S. (2007) · Hypertension · doi:10.1161/01.hyp.0000253507.56499.bb · Cited by 107
Lohmeier, T. E., Iliescu, R., Dwyer, T. M., Irwin, E. D., Cates, A. W., & Rossing, M. A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2010 · Cited by 105
Ye, S., Zhong, H., & Campese, V. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231307.69761.2e · Cited by 104
Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats
Muratani, H., Averill, D. B., & Ferrario, C. M. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.5.r977 · Cited by 103
Swedberg, K., Bristow, M. R., Cohn, J. N., Dargie, H., Straub, M., Wiltse, C., & Wright, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000014212.04920.62 · Cited by 101
Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease
Young, J. M., Terrin, N., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Sarnak, M. J., & Menon, V. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06671208 · Cited by 96
Mallamaci, F., Tripepi, G., Maas, R., Malatino, L., Bo[Combining Diaeresis]ger, R., & Zoccali, C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106717.58091.f6 · Cited by 96
Kumagai, H., Averill, D. B., Khosla, M. C., & Ferrario, C. M. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.476 · Cited by 95
Kishi, T., Hirooka, Y., Ito, K., Sakai, K., Shimokawa, H., & Takeshita, A. (2002) · Hypertension · doi:10.1161/hy0202.102701 · Cited by 94
Physiological genomic analysis of the brain renin-angiotensin system
Davisson, R. L. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00190.2003 · Cited by 93
Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats
Hu, L., Zhu, D., Zhang, Y., Wang, J. Q., Sun, Z., & Yao, T. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00261.2001 · Cited by 91
Hirooka, Y., Potts, P. D., & Dampney, R. A. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00861-5 · Cited by 89
Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis
Volders, P. G. A. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.06.003 · Cited by 88
Kiuchi, M. G., Maia, G. L. M., de Queiroz Carreira, M. A. M., Kiuchi, T., Chen, S., Andrea, B. R., Graciano, M. L., & Lugon, J. R. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht200 · Cited by 88
Thijssen, D. H. J., de Groot, P. M., Kooijman, M., Smits, P., & Hopman, M. T. E. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00240.2006 · Cited by 86
Nishihara, M., Hirooka, Y., Matsukawa, R., Kishi, T., & Sunagawa, K. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834e1df4 · Cited by 85
Sander, M., Hansen, J., & Victor, R. G. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.64 · Cited by 84
Jacob, F., Ariza, P., & Osborn, J. W. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01029.2002 · Cited by 81
Desir, G. V. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f521ba · Cited by 79
Xiao, S., Wagner, L. J., Schmidt, R. J., & Baylis, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041466.x · Cited by 74
Crossover comparison of moxonidine and clonidine in mild to moderate hypertension
Pl�nitz, V. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544037 · Cited by 71
Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move
Zoccali, C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217839.26971.8d · Cited by 70
Recordati, G., Moss, N., Genovesi, S., & Rogenes, P. R. (1981) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(81)90066-7 · Cited by 69
Deo, S. H., Fisher, J. P., Vianna, L. C., Kim, A., Chockalingam, A., Zimmerman, M. C., Zucker, I. H., & Fadel, P. J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00289.2012 · Cited by 67
Self-citationSympathetic Nerve Traffic and Asymmetric Dimethylarginine in Chronic Kidney Disease
Grassi, G. M., Seravalle, G., Ghiadoni, L., Tripepi, G. L., Bruno, R. M., Mancia, G., & Zoccali, C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06970711 · Cited by 62
Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis
Major, R. W., Cheung, C. K., Gray, L. J., & Brunskill, N. J. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07460714 · Cited by 62
Inhibition of nitric oxide synthase evokes central sympatho‐excitation in healthy humans
Young, C. N., Fisher, J. P., Gallagher, K. M., Whaley‐Connell, A. T., Chaudhary, K. R., Victor, R. G., Thomas, G. D., & Fadel, P. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.177204 · Cited by 62
Self-citationIs kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?
Siddiqi, L., Joles, J. A., Grassi, G. M., & Blankestijn, P. J. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832b521b · Cited by 60
UEDA, S., YAMAGISHI, S., KAIDA, Y., & OKUDA, S. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00840.x · Cited by 60
EARLY RENAL DENERVATION PREVENTS DEVELOPMENT OF HYPERTENSION IN GROWTH‐RESTRICTED OFFSPRING
Ojeda, N. B., Johnson, W. R., Dwyer, T. M., & Alexander, B. T. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04754.x · Cited by 59
Meta-analysis of statins in chronic kidney disease: who benefits?
Messow, C., & Isles, C. (2017) · QJM · doi:10.1093/qjmed/hcx040 · Cited by 58
Ibrahim, H. N., Rosenberg, M. E., & Hostetter, T. H. (1997) · PubMed · Cited by 57
Bruno, R. M., Daghini, E., Ghiadoni, L., Sudano, I., Rugani, I., Varanini, M., Passino, C., Emdin, M., & Taddei, S. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035022 · Cited by 57
Gao, L., Wang, W., & Zucker, I. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.136028 · Cited by 57
Plasma Norepinephrine, Epinephrine, and Dopamine Levels in End-Stage Renal Disease
Elias, A. N. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360060069008 · Cited by 56
Sympathetic Mechanisms, Organ Damage, and Antihypertensive Treatment
Grassi, G. M., Seravalle, G., Dell’Oro, R., & Mancia, G. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0200-4 · Cited by 55
Allen, A. M. (2001) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203010020012101 · Cited by 54
dos Santos, A. C., Alves, M. J. N. N., Rondon, M. U. P. B., Barretto, A. C. P., Middlekauff, H. R., & Negrão, C. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01240.2004 · Cited by 54
Park, J., Campese, V. M., Nobakht, N., & Middlekauff, H. R. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90849.2008 · Cited by 54
Takahashi, N., Morimoto, S., Okigaki, M., Seo, M., Someya, K., Morita, T., Matsubara, H., Sugiura, T., & Iwasaka, T. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq547 · Cited by 53
Coutsos, M., Sala‐Mercado, J. A., Ichinose, M., Li, Z., Dawe, E., & O’Leary, D. S. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00879.2012 · Cited by 53
Shi, Z., Chen, A., Xu, Y., Chen, Q., Gao, X.-Y., Wang, W., & Zhu, G. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0627-x · Cited by 48
Medina, A., Bell, P. R. F., Briggs, J. D., Brown, J. J., Fine, A., Lever, A. F., Morton, J. J., Paton, A., Robertson, J. I., Tree, M., et al. (1972) · BMJ · doi:10.1136/bmj.4.5842.694 · Cited by 46
Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction
Cantarin, M. P. M., Whitaker‐Menezes, D., Zhao, L., & Falkner, B. E. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx050 · Cited by 46
l -NAME- and ADMA-induced sympathetic neural activation in conscious rats
Augustyniak, R. A., Victor, R. G., Morgan, D. A., & Zhang, W. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00768.2004 · Cited by 44
Anguiano, L., Riera, M., Pascual, J., Valdivielso, J. M., Barrios, C., Betriu, À., Clotet, S., Mojal, S., Fernández, E., & Soler, M. J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.032 · Cited by 42
Patel, K. P., Mayhan, W. G., Bidasee, K. R., & Zheng, H. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00246.2010 · Cited by 41
The effect of statins on sympathetic activity: a meta-analysis
Lewandowski, J., Symonides, B., Gaciong, Z. A., & Siński, M. (2015) · Clinical Autonomic Research · doi:10.1007/s10286-015-0274-1 · Cited by 40
Gattone, V. H., Siqueira, T. M., Powell, C. R., Trambaugh, C. M., Lingeman, J. E., & Shalhav, A. L. (2008) · Experimental Biology and Medicine · doi:10.3181/0802-rm-54 · Cited by 36
RENAL DENERVATION ATTENUATES LONG‐TERM HYPERTENSIVE EFFECTS OF ANGIOTENSIN II IN THE RAT
Hendel, M. D., & Collister, J. P. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04514.x · Cited by 33
Watson, C., Pazarentzos, E., Fidanboylu, M., Padilla, B., Brown, R. C., & Thomas, S. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.026 · Cited by 33
Katholi, R. E., & Rocha‐Singh, K. J. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.09.003 · Cited by 32
Vitamin C supplementation in kidney failure: effect on uraemic symptoms
Singer, R. F. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq412 · Cited by 28
Chung, C., Lin, M., Hsu, J., Hsiao, J., Chang, S., Pan, K., Lin, C., & Lin, Y. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.001 · Cited by 26
Atorvastatin reduces sympathetic activity in patients with chronic kidney disease
Siddiqi, L., Joles, J. A., Oey, P. L., & Blankestijn, P. J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834ae3c7 · Cited by 25
Wei, S., Zhang, Z., Yang, Y., & Felder, R. B. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283200442 · Cited by 24
Salzer, D. A., Medeiros, P. J., Craen, R. A., & Shoemaker, J. K. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90333.2008 · Cited by 24
Kaplan, J. R., & Manuck, S. B. (1997) · PubMed · Cited by 21
Renal Nerve Ablation for Hypertensive Patients with Chronic Kidney Disease
Papademetriou, V., Doumas, M. N., Anyfanti, P., Faselis, C. J., Kokkinos, P. F., & Tsioufis, C. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113119990143 · Cited by 19
Norepinephrine increases beta-receptors and adenylate cyclase in canine myocardium
Raum, W. J., Laks, M. M., Garner, D., Ikuhara, M. H., & Swerdloff, R. S. (1984) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1984.246.1.h31 · Cited by 18
Role of Renin-Angiotensin-Aldosterone System in the Progression of Renal Disease: A Critical Review
Ibrahim, H. N., Rosenberg, M. E., & Hostetter, T. H. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62848-9 · Cited by 16
Tahara, N., Yamagishi, S., Mizoguchi, M., Tahara, A., & Imaizumi, T. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1434 · Cited by 13
High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure
Gomes, M. E., Messaoudi, S. E., Lenders, J. W. M., Bellersen, L., Verheugt, F. W. A., Smits, P., & Tack, C. J. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01205.x · Cited by 5
Cited by
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 670
Baaten, C. C. F. M. J., Vondenhoff, S., & Noels, H. (2023) · Circulation Research · doi:10.1161/circresaha.123.321752 · Cited by 243
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
Sano, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.12.004 · Cited by 188
Querfeld, U., MAK, R. H. K., & Pries, A. R. (2020) · Clinical Science · doi:10.1042/cs20200279 · Cited by 152
Metadata
- Authors
- Kaur, J., Young, B., & Fadel, P.
- Affiliations
- The University of Texas at Arlington (US)
- Corresponding author
- Fadel, Paul
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-02
- Volume
- 18
- Issue
- 8
- Pages
- 1682
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5578072
- OpenAlex
- W2741868536
- Cited by
- 168
- References
- 156
- Citations by year
- 2026: 19 · 2025: 27 · 2024: 25 · 2023: 14 · 2022: 17 · 2021: 23 · 2020: 16 · 2019: 16 · 2018: 9 · 2017: 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIH R01 HL127071)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- chronic kidney disease, sympathetic nervous system, sympathoexcitation, sympathetic activity, hypertension, cardiovascular risk, chronic kidney disease progression, cardiovascular mortality, therapeutic target
- MeSH terms
- Animals, Humans, Hypertension, Renal, Sympathetic Nervous System, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.